Test Result Won't Hurt Dwyer's Draft Stock

Reports of a failed drug test at the NFL Combine by Georgia Tech running back Jonathan Dwyer won't impact his draft stock one bit. Scout.com's Ed Thompson tells you why.

On Sunday, FOXSports.com's Jay Glazer and Alex Marvez accurately reported that Georgia Tech running back Jonathan Dwyer and USC tight end Anthony McCoy would be named on the confidential list of draft prospects who had failed a drug test at the NFL Scouting Combine in February. And they also shared information that indicated that Dwyer's positive test was triggered by a prescription drug that the star running back has NFL clearance to use, while McCoy's issue was linked to marijuana use.

What's truly unfortunate and unfair to Dwyer is that in today's fast-paced world, some media outlets and fans who repeat the news via the internet and social media only focus on the headlines, not the details.

Dwyer's agent, Adisa Bakari, told Scout.com this morning that all 32 NFL teams were notified by letter prior to the Combine that Dwyer would likely fail the drug test due to a prescribed medication that typically provides a positive result for an amphetamine-like substance, even though it's a prescribed drug that is used to treat a not-uncommon medical condition.

Bakari also provided Scout.com with a letter that was also recently sent to all 32 NFL teams, copying Dr. Lawrence Brown, the NFL Medical Advisor for Substance Abuse and Dr. John Lombardo, the NFL Independent Administrator of the NFL Policy and Procedure for Anabolic Steroids and Related Substances. In that letter, Bakari points out that, "Jonathan is in full compliance with NFL policies relating to banned substances" and that information was provided to both NFL doctors by Dwyer's personal physician to confirm that he qualified for a Therapeutic Use Exemption. "We received email confirmation to that effect from Dr. Lombardo on April 6, 2010," Bakari states in the letter.

"Jonathan's been treated for this medical condition since the fifth grade, so it should be obvious that this isn't a drug abuse issue or a violation of the league's policy on banned substances," Dwyer's agent told Scout.com.

Bakari said that in the most recent letter that was sent to all 32 teams, he also attached the letter from Dwyer's personal physician that was submitted to the NFL doctors to confirm that Dwyer qualified for the Therapeutic Use Exemption.

Based on Dwyer's full disclosure to clubs about his medical condition both before and after the Combine, this public disclosure through the media isn't going to impact his draft stock--regardless of what some media outlets or snippets by fans and sportswriters on Twitter and Facebook might infer. Wherever teams had him slotted on their draft boards a week ago was already determined with the knowledge of Dwyer's medical condition in-hand.

The former Georgia Tech running back rushed for more than 2,700 yards over the past two seasons and logged seventeen 100-yard rushing performances during his three-year collegiate career. He was the ACC Player of the Year in 2008.

You can follow Ed Thompson on Twitter (@Ed_Thompson).

Ed Thompson's player interviews and NFL features are published across the Scout.com network and at FOXSports.com.

Scout NFL Network Top Stories